SCHEMBL10013468

SCHEMBL10013468

Cc1ccc(-c2cnc(-c3ccc4cc5cc(-c6ncc(-c7ccc(C)s7)s6)ccc5cc4c3)s2)s1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 1/20 0.41
▸ HSD17B1 P14061 3/20 0.41
▸ HSD17B2 P37059 3/20 0.41
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ SNCA P37840 3/20 0.38
▸ RARA P10276 3/20 0.37
▸ RARB P10826 3/20 0.37
▸ RARG P13631 3/20 0.37
▸ NPC1 O15118 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ MAPT P10636 1/20 0.33
▸ GFER P55789 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ DYRK1A Q13627 1/20 0.32
▸ ABL1 P00519 2/20 0.32
▸ XDH P47989 1/20 0.32
▸ IRAK4 Q9NWZ3 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.31
▸ HPGDS O60760 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13142468 0.86 HSD17B1 (0.45) HSD17B1HSD17B2CYP3A4CYP2C9SNCA
SCHEMBL10013478 0.83 HSD17B1 (0.49) HSD17B1HSD17B2CYP3A4CYP2C9SNCA
SCHEMBL10013479 0.82 HSD17B1 (0.49) HSD17B1HSD17B2CYP3A4CYP2C9SNCA
SCHEMBL10628362 0.80 ALDH1A1 (0.44) HSD17B1HSD17B2CYP3A4CYP2C9SNCA
SCHEMBL19143572 0.80 PGR (0.55) PGRHSD17B1HSD17B2CYP3A4CYP2C9
SCHEMBL12170052 0.79 NPC1 (0.39) HSD17B1HSD17B2CYP3A4CYP2C9NPC1
SCHEMBL13142445 0.79 HSD17B1 (0.54) HSD17B1HSD17B2CYP3A4CYP2C9SNCA
SCHEMBL13142444 0.79 HSD17B1 (0.54) HSD17B1HSD17B2CYP3A4CYP2C9SNCA
SCHEMBL10013480 0.78 HSD17B1 (0.44) HSD17B1HSD17B2CYP3A4CYP2C9SNCA
SCHEMBL10013473 0.78 HSD17B1 (0.44) PGRHSD17B1HSD17B2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148543-B2 A benzene or polycondensed aromatic ring substituted with substituted thiazole groups; storage stability and high ON current CANON KABUSHIKI KAISHA (JP) 2012-04-03 — — US disclosed
US-8148543-B2 A benzene or polycondensed aromatic ring substituted with substituted thiazole groups; storage stability and high ON current CANON KABUSHIKI KAISHA (JP) 2012-04-03 — — US disclosed
US-20080087884-A1 ORGANIC SEMICONDUCTOR MATERIAL AND ORGANIC THIN-FILM TRANSISTOR CANON KABUSHIKI KAISHA (JP) 2008-04-17 — — US disclosed
US-20080087884-A1 ORGANIC SEMICONDUCTOR MATERIAL AND ORGANIC THIN-FILM TRANSISTOR CANON KABUSHIKI KAISHA (JP) 2008-04-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080087884-A1 ORGANIC SEMICONDUCTOR MATERIAL AND ORGANIC THIN-FILM TRANSISTOR SLC19A2, TCP1, TTI1 PGR 2943/4885HSD17B1 1220/4885HSD17B2 2253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback